When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ...
Morning Overview on MSN
The FDA just cleared a new kind of br...
For roughly four in every ten women whose estrogen receptor-positive breast cancer has spread and stopped responding to ...
CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...
Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy often fails even when tumors express the hormone receptor that should make ...
Peptides continue to occupy a persuasive position within contemporary biochemical and molecular investigations.
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors Overall, 262 patients with ER+/HER2– ...
Researchers confirm and explore the role of estrogen-related receptors in regulating energy production in muscle cells during exercise. The findings indicate that developing a drug to boost ...
How an AgriLife Research scientist uncovered the unexpected roles of ghrelin, the hunger hormone, in aging and brain health.
Immune cells in the uterus shortly after mating. Panels A–F show CD45+ immune cells, and panels G–L show ELANE+ neutrophils at two time points: 0.5 days (D0.5) and 3.5 days (D3.5) after mating. (A, G) ...
Estrogen-dependent cancers are cancers that grow in response to the hormone estrogen. These include certain types of breast cancer, uterine cancer, and ovarian cancer. In these cancers, estrogen can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results